Fairfield, Bush & Co. Illumina, Inc. Transaction History

Fairfield, Bush & Co.

  • $168 Billion
  • Q3 2024

A detailed history of Fairfield, Bush & Co. transactions in Illumina, Inc. stock. As of the latest transaction made, Fairfield, Bush & Co. holds 8,037 shares of ILMN stock, worth $1.09 Million. This represents 0.62% of its overall portfolio holdings.

Number of Shares
8,037
Previous 7,915 1.54%
Holding current value
$1.09 Million
Previous $826 Million 26.86%
% of portfolio
0.62%
Previous 0.5%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
BUY
$105.28 - $135.9 $12,844 - $16,579
122 Added 1.54%
8,037 $1.05 Billion
Q2 2024

Aug 15, 2024
SELL
$101.05 - $133.57 $16,168 - $21,371
-160 Reduced 1.98%
7,915 $826 Million
Q1 2024

May 15, 2024
BUY
$127.73 - $147.2 $60,416 - $69,625
473 Added 6.22%
8,075 $1.11 Billion
Q4 2023

Feb 13, 2024
BUY
$92.79 - $142.53 $30,620 - $47,034
330 Added 4.54%
7,602 $1.06 Billion
Q3 2023

Nov 15, 2023
SELL
$128.91 - $192.44 $1.33 Million - $1.99 Million
-10,350 Reduced 58.73%
7,272 $998 Million
Q2 2023

Aug 15, 2023
BUY
$183.43 - $232.67 $497,095 - $630,535
2,710 Added 18.17%
17,622 $3.3 Billion
Q1 2023

May 15, 2023
BUY
$193.75 - $232.55 $1.57 Million - $1.89 Million
8,125 Added 119.71%
14,912 $3.47 Billion
Q4 2022

Feb 14, 2023
SELL
$187.24 - $242.74 $93,620 - $121,370
-500 Reduced 6.86%
6,787 $1.37 Billion
Q3 2022

Nov 07, 2022
BUY
$177.23 - $227.44 $62,916 - $80,741
355 Added 5.12%
7,287 $1.39 Million
Q2 2022

Aug 09, 2022
BUY
$181.58 - $368.0 $107,313 - $217,488
591 Added 9.32%
6,932 $1.28 Million
Q4 2021

Feb 09, 2022
SELL
$347.28 - $421.83 $2.66 Million - $3.23 Million
-7,653 Reduced 54.69%
6,341 $2.41 Million
Q3 2021

Nov 08, 2021
SELL
$405.61 - $524.84 $70,981 - $91,847
-175 Reduced 1.24%
13,994 $5.68 Million
Q2 2021

Aug 02, 2021
BUY
$372.84 - $481.5 $46,605 - $60,187
125 Added 0.89%
14,169 $6.71 Million
Q1 2021

May 14, 2021
SELL
$361.28 - $504.76 $504,708 - $705,149
-1,397 Reduced 9.05%
14,044 $5.39 Million
Q4 2020

Feb 12, 2021
SELL
$292.7 - $370.96 $9,073 - $11,499
-31 Reduced 0.2%
15,441 $5.71 Million
Q3 2020

Nov 18, 2020
BUY
$268.51 - $400.74 $70,886 - $105,795
264 Added 1.74%
15,472 $4.78 Million
Q2 2020

Aug 13, 2020
SELL
$256.46 - $373.01 $167,468 - $243,575
-653 Reduced 4.12%
15,208 $5.63 Million
Q1 2020

May 13, 2020
BUY
$209.2 - $335.53 $38,702 - $62,073
185 Added 1.18%
15,861 $4.33 Million
Q4 2019

Feb 12, 2020
BUY
$288.29 - $335.49 $57,658 - $67,098
200 Added 1.29%
15,676 $5.2 Million
Q3 2019

Nov 13, 2019
SELL
$266.84 - $378.23 $22,681 - $32,149
-85 Reduced 0.55%
15,476 $4.71 Million
Q2 2019

Aug 13, 2019
SELL
$300.59 - $368.15 $116,328 - $142,474
-387 Reduced 2.43%
15,561 $5.73 Million
Q1 2019

May 15, 2019
SELL
$272.57 - $321.18 $125,382 - $147,742
-460 Reduced 2.8%
15,948 $4.96 Million
Q4 2018

Feb 11, 2019
SELL
$272.46 - $366.54 $120,699 - $162,377
-443 Reduced 2.63%
16,408 $4.92 Million
Q3 2018

Nov 13, 2018
SELL
$279.04 - $367.06 $77,015 - $101,308
-276 Reduced 1.61%
16,851 $6.19 Million
Q2 2018

Aug 16, 2018
SELL
$228.17 - $292.07 $134,392 - $172,029
-589 Reduced 3.32%
17,127 $4.78 Million
Q1 2018

May 09, 2018
SELL
$209.54 - $253.91 $265,906 - $322,211
-1,269 Reduced 6.68%
17,716 $4.19 Million
Q4 2017

Feb 22, 2018
BUY
$202.23 - $230.03 $51,568 - $58,657
255 Added 1.36%
18,985 $4.15 Million
Q3 2017

Nov 14, 2017
SELL
$172.3 - $213.93 $56,686 - $70,382
-329 Reduced 1.73%
18,730 $3.73 Million
Q2 2017

Aug 15, 2017
BUY
N/A
19,059
19,059 $3.31 Million

Others Institutions Holding ILMN

# of Institutions
900
Shares Held
137M
Call Options Held
1.22M
Put Options Held
1.43M
View Full List

About ILLUMINA, INC.

ILMN Quotes by TradingView
  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $21.3B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track This Portfolio

Track Fairfield, Bush & Co. Portfolio

Follow Fairfield, Bush & Co. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fairfield, Bush & Co., based on Form 13F filings with the SEC.

News

Stay updated on Fairfield, Bush & Co. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email